Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 720 | 673 | 1,773 | 1,875 | 705 |
| Cost of Goods | 945 | 7,175 | 3,675 | 4,132 | 6,147 |
| Gross Profit | -225 | -6,502 | -1,902 | -2,257 | -5,442 |
| Operating Expenses | 5,775 | 3,656 | 6,370 | 7,316 | 7,708 |
| Operating Income | -5,055 | -9,983 | -7,597 | -9,441 | -13,003 |
| Interest Expense | 1,960 | 2,050 | 1,969 | 2,198 | 2,229 |
| Other Income | 3,653 | 9,015 | 4,128 | -811 | 14,828 |
| Pre-tax Income | -3,362 | -3,018 | -5,438 | -12,450 | -404 |
| Net Income Continuous | -3,362 | -3,018 | -5,438 | -12,450 | -404 |
| Net Income | $-3,362 | $-3,018 | $-5,438 | $-12,450 | $-404 |
| EPS Basic Total Ops | -0.16 | -0.16 | -0.27 | -0.63 | -0.02 |
| EPS Basic Continuous Ops | -0.16 | -0.15 | -0.28 | -0.63 | -0.02 |
| EPS Diluted Total Ops | -0.16 | -0.16 | -0.27 | -0.63 | -0.02 |
| EPS Diluted Continuous Ops | -0.16 | -0.15 | -0.28 | -0.63 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.59 | -0.27 | -0.63 | -0.75 |
| EBITDA(a) | $-3,908 | $-8,685 | $-6,429 | $-8,150 | $-11,432 |